Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 12Terminated 5Active not recruiting 4Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 15Ovarian Neoplasms 9Recurrence 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2Carcinoma, Ovarian Epithelial 2Uterine Cervical Neoplasms 1Unrecognized Condition 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasm Epithelial 1Muscle Invasive Bladder Cancer 1Mesothelioma, Malignant 1Lymphoma, Mantle-Cell 1Lymphoma 1Leukemia, Plasma Cell 1Hodgkin Disease 1HER2-positive Breast Cancer 1Genetic Predisposition to Disease 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Advanced Solid Tumors 1Advanced Breast Cancer 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neoplasms × liposomal doxorubicin × Clear all
NCT01715168 2015-01-15

A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

Azaya Therapeutics, Inc.

Phase 1 Unknown
40 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT00531973 2009-02-18

LITE

Catholic University, Italy

Phase 4 Unknown
80 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡